Select a medication above to begin.
Stelara
ustekinumab
Adult Dosing .
Dosage forms: INJ (pre-filled syringe): 45 mg per 0.5 mL, 90 mg per mL; INJ (vial, SC): 45 mg per 0.5 mL; INJ (vial, IV): various
psoriasis, moderate-severe plaque
- [<100 kg]
- Dose: 45 mg SC q12wk; Start: 45 mg SC x1 on wk 0, 4, then q12wk
- [>100 kg]
- Dose: 90 mg SC q12wk; Start: 90 mg SC x1 on wk 0, 4, then q12wk; Info: may decr. dose to 45 mg if full dose intolerable
psoriatic arthritis
- [45 mg SC q12wk]
- Start: 45 mg SC x1 on wk 0, 4, then q12wk; Info: give 90 mg SC x1 on wk 0, 4, then q12wk if >100 kg w/ coexisting plaque psoriasis
Crohn dz, moderate-severe
- [induction tx, <55kg]
- Dose: 260 mg IV x1
- [induction tx, 55-85kg]
- Dose: 390 mg IV x1
- [induction tx, >85kg]
- Dose: 520 mg IV x1
- [maintenance tx]
- Dose: 90 mg SC q8wk; Start: 8wk after induction dose
ulcerative colitis, moderate-severe
- [induction tx, <55kg]
- Dose: 260 mg IV x1
- [induction tx, 55-85kg]
- Dose: 390 mg IV x1
- [induction tx, >85kg]
- Dose: 520 mg IV x1
- [maintenance tx]
- Dose: 90 mg SC q8wk; Start: 8wk after induction dose
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ (pre-filled syringe): 45 mg per 0.5 mL, 90 mg per mL; INJ (vial, SC): 45 mg per 0.5 mL; INJ (vial, IV): various
psoriasis, moderate-severe plaque
- [6 yo and older, <60 kg]
- Dose: 0.75 mg/kg/dose SC q12wk; Start: 0.75 mg/kg/dose SC x1 on wk 0, 4, then q12wk
- [6 yo and older, 60-100 kg]
- Dose: 45 mg SC q12wk; Start: 45 mg SC x1 on wk 0, 4, then q12wk
- [6 yo and older, >100 kg]
- Dose: 90 mg SC q12wk; Start: 90 mg SC x1 on wk 0, 4, then q12wk
psoriatic arthritis
- [6 yo and older, <60 kg]
- Dose: 0.75 mg/kg/dose SC q12wk; Start: 0.75 mg/kg/dose SC x1 on wk 0, 4, then q12wk
- [6 yo and older, >60 kg]
- Dose: 45 mg SC q12wk; Start: 45 mg SC x1 on wk 0, 4, then q12wk; Info: give 90 mg SC x1 on wk 0, 4, then q12wk if >100 kg w/ coexisting plaque psoriasis
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]